This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Regents of the University of Minnesota. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Hemant Kumar Mishra: Innovator in Chimeric IgG Fc Receptor Treatments
Introduction
Hemant Kumar Mishra is a notable inventor based in Minneapolis, MN (US). He has made significant contributions to the field of medical treatments, particularly through his innovative patent.
Latest Patents
Mishra holds a patent titled "Treatments Administering Chimeric IgG Fc Receptor Comprising an Extracellular Domain of CD64." This patent represents a crucial advancement in therapeutic methods, showcasing his expertise and dedication to improving healthcare.
Career Highlights
He is affiliated with the Regents of the University of Minnesota, where he continues to engage in groundbreaking research. His work has the potential to impact various medical applications, particularly in immunology.
Collaborations
Mishra collaborates with esteemed colleagues such as Jianming Wu and Bruce Kenneth Walcheck. Their combined efforts contribute to the advancement of innovative treatments and research in their field.
Conclusion
Hemant Kumar Mishra is a distinguished inventor whose work in chimeric IgG Fc receptor treatments exemplifies his commitment to medical innovation. His contributions are paving the way for future advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile